S
Sirnaomics Ltd
HKEX:2257
Sirnaomics Ltd
HKEX:2257
Price:
7.12 HKD
-2.6%
Market Closed
Updated:
May 4, 2024
Sirnaomics Ltd
Cash from Financing Activities
|
Sirnaomics Ltd
Cash from Financing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Sirnaomics Ltd
HKEX:2257
|
Cash from Financing Activities
$15.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is Sirnaomics Ltd's Cash from Financing Activities?
Cash from Financing Activities
15.9m
USD
15.9m
USD
Based on the financial report for Dec 31, 2022, Sirnaomics Ltd's Cash from Financing Activities amounts to 15.9m USD.
What is Sirnaomics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
11%
11%
Over the last year, the Cash from Financing Activities growth was -91%. The average annual Cash from Financing Activities growth rates for Sirnaomics Ltd have been 11% over the past three years .
You don't have any saved screeners yet
